CI
ASND icon

Capital International’s Ascendis Pharma A/S ASND Stock Holding History

Capital International’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.37M Hold
16,394
– – 0.14% 115
2026
Q1 		$3.75M Sell
16,394
-467
-3% -$105K 0.14% 117
2025
Q4 		$3.6M Sell
16,861
-4,811
-22% -$994K 0.13% 123
2025
Q3 		$4.31M Buy
21,672
+1,174
+6% +$219K 0.16% 118
2025
Q2 		$3.54M Buy
20,498
+297
+1% +$48.4K 0.14% 119
2025
Q1 		$3.15M Buy
20,201
+1,048
+5% +$150K 0.14% 119
2024
Q4 		$2.64M Buy
+19,153
New +$2.52M 0.11% 129

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital International's ASND Position: Q2 2026 in Review

Capital International held its Ascendis Pharma A/S (ASND) position steady in Q2 2026 at 16,394 shares worth $4.37M. The position accounts for 0.14% of the portfolio, ranked #115.

Capital International first reported a position in ASND in Q4 2024 and has held it in 7 quarters since. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Capital International held 16,394 shares of Ascendis Pharma A/S worth $4.37M as of Q2 2026.
  • Capital International left its Ascendis Pharma A/S share count unchanged in Q2 2026.
  • Ascendis Pharma A/S made up 0.14% of Capital International's portfolio in Q2 2026, its #115 holding.
  • Capital International first reported a position in Ascendis Pharma A/S in Q4 2024 and has held it in 7 quarters since.
  • 312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Capital International's 13F filing for Q2 2026, filed 12 Aug 2026.